Saturday, 31 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Investor Presentation

Gem Aromatics Investor Presentation: Key Takeaways

Q2FY27 consolidated revenue Rs 104.0 Cr (+16.2% YoY) with PAT loss Rs 7.0 Cr; EBITDA margin 7.6%. Standalone PAT Rs 8.9 Cr. Dahej capex (~Rs 265 Cr) capitalised; new specialty molecules ramping.

Highlights
Revenue growthConsolidated Q2 +16.2% YoY; standalone -6.1% YoY.
MarginsConsolidated EBITDA margin 7.6% vs 3.4% YoY; gross margin 25.4%.
Demand visibilityCustomer qualifications ongoing; seeking recurring commercial business.
Management confidenceMeasured tone; seasonally softer quarter framing; no numeric targets.

Growth

Consolidated Q2 revenue +16.2% YoY; H1 revenue Rs 202.8 Cr (+14.5%). Standalone Q2 revenue -6.1% YoY.

Outlook

New products earn revenue from Q3FY27 (cooling agents, Safranal) and Q4FY27 (MEHQ). Brazil subsidiary proposed. Dahej total capex ~Rs 270 Cr.

Risks

Dahej depreciation Rs 9.5 Cr/quarter, finance cost Rs 4.7 Cr. H1 operating cash flow Rs -81.3 Cr on working capital build.

Last quarter's promises, checked

Delivered

  • Guided Dahej capex ~Rs 270 Cr → ~Rs 265 Cr capitalised, total ~Rs 270 Cr (= BEAT)

Partly delivered

  • Guided demand back to normal, export ramp in Q2-Q3 → consolidated Q2 revenue +16.2% YoY, standalone -6.1% (= PARTIAL)

Missed

  • Guided Safranal revenue by end-Q2 FY27 → revenue now from Q3 FY27 (= MISS)
Source

Investor Presentation filed with NSE, NSE: GEMAROMA. Summary written with AI assistance from the document.

Read the document ↗

Gem Aromatics Ltd: key numbers

Share price
₹137.04
Market cap
₹715.9 Cr
Revenue (annual)
₹366.5 Cr
Net profit (annual)
₹1.42 Cr
P/E (TTM)
-49.6×Sector 34.1×
Promoter holding
57.45%+0.00% QoQ
FII holding
0.39%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Gem Aromatics Ltd

All →